| Inflammatory Myopathies and Dermatomyositis | Lifetime | 13 | JP 2 | 99.58 |
| Muscle Physiology and Disorders | Lifetime | 47 | JP 2 | 99.50 |
| Mitochondrial Function and Pathology | Lifetime | 189 | JP 4 | 99.20 |
| Metabolism and Genetic Disorders | Lifetime | 192 | JP 9 | 99.10 |
| Cardiomyopathy and Myosin Studies | Lifetime | 132 | JP 7 | 99.03 |
| Genetic Neurodegenerative Diseases | Lifetime | 169 | JP 9 | 98.90 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 70 | JP 2 | 98.32 |
| Autophagy in Disease and Therapy | Lifetime | 250 | JP 26 | 98.16 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 156 | JP 6 | 98.27 |
| Eosinophilic Disorders and Syndromes | Lifetime | 248 | JP 10 | 97.98 |
| Cellular transport and secretion | Lifetime | 346 | JP 21 | 98.09 |
| Lysosomal Storage Disorders Research | Lifetime | 198 | JP 12 | 97.64 |
| Nuclear Structure and Function | Lifetime | 114 | JP 6 | 97.04 |
| Biochemical and Molecular Research | Lifetime | 556 | JP 24 | 96.70 |
| ATP Synthase and ATPases Research | Lifetime | 795 | JP 66 | 93.14 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 171 | JP 11 | 92.54 |
| Skin Diseases and Diabetes | Lifetime | 325 | JP 27 | 91.12 |
| Caveolin-1 and cellular processes | Lifetime | 742 | JP 56 | 85.03 |
| Calpain Protease Function and Regulation | Lifetime | 428 | JP 71 | 85.26 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 372 | JP 43 | 44.22 |
| Muscle Physiology and Disorders | 2021-2025 | 17 | JP 1 | 98.77 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 23 | JP 1 | 98.19 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 18 | JP 2 | 98.69 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 134 | JP 1 | 96.47 |
| Skin Diseases and Diabetes | 2021-2025 | 22 | JP 1 | 90.54 |
| Cellular transport and secretion | 2021-2025 | 117 | JP 7 | 91.77 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 159 | JP 4 | 93.09 |
| Nuclear Structure and Function | 2021-2025 | 55 | JP 2 | 88.75 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 77 | JP 1 | 88.42 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 347 | JP 16 | 89.18 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 803 | JP 22 | 84.44 |
| Dermatological and Skeletal Disorders | 2021-2025 | 139 | JP 7 | 78.03 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 617 | JP 50 | 72.92 |
| Connective tissue disorders research | 2021-2025 | 647 | JP 47 | 69.71 |
| Celiac Disease Research and Management | 2021-2025 | 634 | JP 10 | 70.53 |
| Hereditary Neurological Disorders | 2021-2025 | 547 | JP 30 | 66.62 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 197 | JP 21 | 66.84 |
| Neurological diseases and metabolism | 2021-2025 | 716 | JP 36 | 63.37 |
| Muscle and Compartmental Disorders | 2021-2025 | 502 | JP 42 | 60.92 |
| Skin and Cellular Biology Research | 2021-2025 | 651 | JP 42 | 58.26 |
| Calpain Protease Function and Regulation | 2021-2025 | 141 | JP 13 | 32.78 |
| Heterotopic Ossification and Related Conditions | 2021-2025 | 457 | JP 49 | 25.45 |
